Strikingly, oligoadenylate synthetase 1 (OAS1), a newly reported risk gene for AD, was recently identified as a putative risk gene associated with severe COVID-19 in intensive care patients in human genome-wide association studies [150, 151]. This evidence concerns the gene OAS1 and Alzheimer disease.